← All trials

NCT04701164

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 17, 2020
Primary completion
Mar 31, 2023
Completion date
Mar 31, 2023
First posted
Jan 8, 2021
Last posted
Jan 8, 2021
Enrollment
180
Arms / groups
3 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.